The human metapneumovirus fusion protein mediates entry via an interaction with RGD-binding integrins

Journal of Virology

Volumn 86, Issue 22, 2012, Pages 12148-12160

  Cox, Reagan G ^a   Brent Livesay, S ^b   Johnson, Monika ^a   Ohi, Melanie D ^b   Williams, John V ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTYLSERINE; HUMAN METAPNEUMOVIRUS FUSION PROTEIN; INTEGRIN; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; BINDING AFFINITY; CELL FUSION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN METAPNEUMOVIRUS; HUMAN METAPNEUMOVIRUS INFECTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; RNA TRANSCRIPTION; VIROGENESIS; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS GENOME; VIRUS PARTICLE;

AMINO ACID MOTIFS; CELL LINE; FLOW CYTOMETRY; HUMANS; INTEGRINS; MEMBRANE FUSION; METAPNEUMOVIRUS; MICROSCOPY, ELECTRON; OLIGOPEPTIDES; PROTEIN BINDING; RECEPTORS, VITRONECTIN; RECOMBINANT PROTEINS; VIRAL FUSION PROTEINS; VIRION; VIRUS INTERNALIZATION;

HUMAN METAPNEUMOVIRUS;

EID: 84869118316     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01133-12     Document Type: Article

References (41)

1. Aguilar HC, et al. 2009. A novel receptor-induced activation site in the Nipah virus attachment glycoprotein (G) involved in triggering the fusion glycoprotein (F). J. Biol. Chem. 284:1628-1635.
2. Ali SA, et al. 2011. Real-world comparison of two molecular methods for detection of respiratory viruses. Virol. J. 8:332.
3. Applied Biosystems. 2001. User bulletin 2: ABI PRISM 7700 sequence detection system. Applied Biosystems, Foster City, CA.
4. Biacchesi S, et al. 2005. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessentialaccessory protein and identifies vaccine candidates. J. Virol. 79:12608-12613.
5. Biacchesi S, et al. 2004. Recombinant human metapneumovirus lacking the small hydrophobic SH and/or attachment G glycoprotein: deletion of G yields a promising vaccine candidate. J. Virol. 78:12877-12887.
6. Buchholz UJ, Finke S, Conzelmann KK. 1999. Generation of bovine respiratory syncytial virus (BRSV) from cDNA: BRSV NS2 is not essential for virus replication in tissue culture, and the human RSV leader region acts as a functional BRSV genome promoter. J. Virol. 73:251-259.
7. Chang A, Masante C, Buchholz UJ, Dutch RE.2012. Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate. J. Virol. 86:3230-3243.
8. Colman PM, Lawrence MC. 2003. The structural biology of type I viral membrane fusion. Nat. Rev. Mol. Cell Biol. 4:309-319.
9. Connolly SA, Leser GP, Jardetzky TS, Lamb RA. 2009. Bimolecular complementation of paramyxovirus fusion and hemagglutininneuraminidase proteins enhances fusion: implications for the mechanism of fusion triggering. J. Virol. 83:10857-10868.
10. Connolly SA, Leser GP, Yin HS, Jardetzky TS, Lamb RA. 2006. Refolding of a paramyxovirus F protein from prefusion to postfusion conformations observed by liposome binding and electron microscopy. Proc. Natl.Acad. Sci. U. S. A. 103:17903-17908.
11. Cseke G, et al. 2009. Integrin alphavbeta1 promotes infection by human metapneumovirus. Proc. Natl. Acad. Sci. U. S. A. 106:1566-1571.
12. Cseke G, et al. 2007. Human metapneumovirus fusion protein vaccines that are immunogenic and protective in cotton rats. J. Virol. 81:698-707.
13. Herfst S, et al. 2004. Recovery of human metapneumovirus genetic lineages A and B from cloned cDNA. J. Virol. 78:8264-8270.
14. Herfst S, et al. 2008. Low-pH-induced membrane fusion mediated by human metapneumovirus F protein is a rare, strain-dependent phenomenon.J. Virol. 82:8891-8895.
15. Hoekstra D, de Boer T, Klappe K, Wilschut J. 1984. Fluorescence method for measuring the kinetics of fusion between biological membranes. Biochemistry 23:5675-5681.
16. Humphries JD, Byron A, Humphries MJ. 2006. Integrin ligands at a glance. J. Cell Sci. 119:3901-3903.
17. Karron RA, et al. 1997. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc. Natl. Acad. Sci. U. S. A. 94:13961-13966.
18. Krishnan A, et al. 2009. A histidine switch in hemagglutininneuraminidase triggers paramyxovirus-cell membrane fusion. J. Virol. 83: 1727-1741.
19. Lamb RA, Jardetzky TS. 2007. Structural basis of viral invasion: lessons from paramyxovirus F. Curr. Opin. Struct. Biol. 17:427-436.
20. Lee JK, et al. 2008. Functional interaction between paramyxovirus fusion and attachment proteins. J. Biol. Chem. 283:16561-16572.
21. Liu L, Bastien N, Li Y. 2007. Intracellular processing, glycosylation, and cell surface expression of human metapneumovirus attachment glycoprotein.J. Virol. 81:13435-13443.
22. Livak KJ, Schmittgen TD. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
23. Mahon PJ, Mirza AM, Iorio RM. 2011. Role of the two sialic acid binding sites on the Newcastle disease virus HN protein in triggering the interaction with the F protein required for the promotion of fusion. J. Virol. 85:12079-12082.
24. Mas V, Herfst S, Osterhaus AD, Fouchier RA, Melero JA. 2011. Residues of the human metapneumovirus fusion (F) protein critical for its strainrelated fusion phenotype: implications for the virus replication cycle. J.Virol. 85:12650-12661.
25. Melanson VR, Iorio RM. 2006. Addition of N-glycans in the stalk of the Newcastle disease virus HN protein blocks its interaction with the F protein and prevents fusion. J. Virol. 80:623-633.
26. Ohi M, Li Y, Cheng Y, Walz T. 2004. Negative staining and image classification-powerful tools in modern electron microscopy. Biol. Proc. Online 6:23-34.
27. Pfaffl MW. 2001. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e45. doi:10.1093/nar/29.9.e45.
28. Plemper RK, Hammond AL, Gerlier D, Fielding AK, Cattaneo R. 2002.Strength of envelope protein interaction modulates cytopathicity of measles virus. J. Virol. 76:5051-5061.
29. Porotto M, Murrell M, Greengard O, Moscona A. 2003. Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutininneuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion. J. Virol. 77:3647-3654.
30. Russell CJ, Kantor KL, Jardetzky TS, Lamb RA. 2003. A dual-functional paramyxovirus F protein regulatory switch segment: activation and membrane fusion. J. Cell Biol. 163:363-374.
31. Ryder AB, Tollefson SJ, Podsiad AB, Johnson JE, Williams JV. 2010.Soluble recombinant human metapneumovirus G protein is immunogenic but not protective. Vaccine 28:4145-4152.
32. Schowalter RM, Chang A, Robach JG, Buchholz UJ, Dutch RE. 2009.Low-pH triggering of human metapneumovirus fusion: essential residues and importance in entry. J. Virol. 83:1511-1522.
33. Schowalter RM, Smith SE, Dutch RE. 2006. Characterization of human metapneumovirus F protein-promoted membrane fusion: critical roles for proteolytic processing and low pH. J. Virol. 80:10931-10941.
34. Smith EC, Popa A, Chang A, Masante C, Dutch RE. 2009. Viral entry mechanisms: the increasing diversity of paramyxovirus entry. FEBS J. 276:7217-7227.
35. Stewart PL, Nemerow GR. 2007. Cell integrins: commonly used receptors for diverse viral pathogens. Trends Microbiol. 15:500-507.
36. Tanabayashi K, Compans RW. 1996. Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion. J. Virol. 70:6112-6118.
37. Thammawat S, Sadlon TA, Hallsworth PG, Gordon DL. 2008. Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection. J. Virol. 82:11767-11774.
38. Ulbrandt ND, et al. 2006. Isolation and characterization of monoclonal antibodies which neutralize human metapneumovirus in vitro and in vivo. J. Virol. 80:7799-7806.
39. Williams JV, et al. 2007. A recombinant human monoclonal antibody to human metapneumovirus fusion protein that neutralizes virus in vitro and is effective therapeutically in vivo. J. Virol. 81:8315-8324.
40. Williams JV, Tollefson SJ, Johnson JE, and Crowe JE, Jr. 2005. The cotton rat (Sigmodon hispidus) is a permissive small animal model of human metapneumovirus infection, pathogenesis, and protective immunity.J. Virol. 79:10944-10951.
41. Yang CF, et al. 2009. Genetic diversity and evolution of human metapneumovirus fusion protein over twenty years. Virol. J. 6:138.